0001140361-24-008025.txt : 20240214 0001140361-24-008025.hdr.sgml : 20240214 20240214164420 ACCESSION NUMBER: 0001140361-24-008025 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Bioceres Crop Solutions Corp. CENTRAL INDEX KEY: 0001769484 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-90962 FILM NUMBER: 24639602 BUSINESS ADDRESS: STREET 1: PO BOX 309, UGLAND HOUSE CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 54 341 486 1122 MAIL ADDRESS: STREET 1: OCAMPO 210 BIS, PREDIO CCT CITY: ROSARIO STATE: C1 ZIP: 2000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Solel Partners LP CENTRAL INDEX KEY: 0001790604 ORGANIZATION NAME: IRS NUMBER: 384104465 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 699 BOYLSTON STREET STREET 2: 15TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6177027388 MAIL ADDRESS: STREET 1: 699 BOYLSTON STREET STREET 2: 15TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 SC 13G/A 1 ef20021543_sc13ga.htm SC 13G/A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

 
SCHEDULE 13G
 
Under the Securities Exchange Act of 1934
(Amendment No. 1) *
 
BIOCERES CROP SOLUTIONS CORP.
 
ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE
 (Title of Class of Securities)
 
G1117K114
 (CUSIP Number)
 
 December 31, 2023
 (Date of Event which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
  ☒
Rule 13d-1(b)
 
  ☐
Rule 13d-1(c)
 
  ☐
Rule 13d-1(d)
 
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
Continued on following pages
Page 1 of 5 Pages

CUSIP No. G1117K114
Page 2 of 5 Pages
1
NAMES OF REPORTING PERSONS
 
 
SOLEL PARTNERS, LP
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    
(a)☐
    
(b)☐
 
 
3
SEC USE ONLY
 
 

 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Delaware
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
 
 
4,579,364
 
 
 
 
6
SHARED VOTING POWER
 
 
0
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
4,579,364
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
4,579,364
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
☐
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
 
7.3%
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
IA
 
 
 
 

Page 3 of 5 Pages
Item 1(a).
Name of Issuer:

Bioceres Crop Solutions Corp.

Item 1(b).
Address of Issuer’s Principal Executive Offices:

Ocampo 210 bis, Predio CCT, Rosario
Province of Santa Fe, Argentina

Item 2(a).
Name of Person Filing

Solel Partners LP (the “Reporting Person”)

Item 2(b).
Address of Principal Business Office or, if None, Residence:

Solel Partners LP
699 Boylston Street, 15th Floor
Boston, MA 02116

Item 2(c).
Citizenship:

United States - Delaware

Item 2(d).
Title of Class of Securities:
 
Ordinary shares, par value $0.0001 per share (the “Shares”)

Item 2(e).
CUSIP Number:

G1117K114

Item 3.
If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

(e)
☒
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

Item 4.
Ownership:

Item 4(a).
Amount Beneficially Owned:  4,579,364

Item 4(b).
Percent of Class: 7.3%

Item 4(c).
Number of Shares as to which such person has:
 
(i) Sole power to vote or direct the vote: 4,579,364
 
(ii) Shared power to vote or direct the vote: 0
 
(iii) Sole power to dispose or direct the disposition of: 4,579,364
 
(iv) Shared power to dispose or direct the disposition of: 0

Page 4 of 5 Pages
Item 5.
Ownership of Five Percent or Less of a Class:

This Item 5 is not applicable.

Item 6.
Ownership of More than Five Percent on Behalf of Another Person:

Solel-Bioceres SPV, L.P. is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Statement that may be deemed to be beneficially owned by the Reporting Person.

Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

This Item 7 is not applicable.

Item 8.
Identification and Classification of Members of the Group:

This Item 8 is not applicable.

Item 9.
Notice of Dissolution of Group:

This Item 9 is not applicable.

Item 10.
Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
Page 5 of 5 Pages
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 14, 2024
  
 
Solel Partners LP
   
 
By: 
 /s/ William Stone
 
Name: William Stone
 
Title: Chief Compliance Officer